TFRC and cancer: Multiple strategies for anticancer therapies, including utilization of TFRC-mediated cytotoxic drug conjugates and iron chelators, have been designed to disrupt the intracellular iron balance needed to meet the urgent metabolic demand of cancer cells 62.